1. Home
  2. CHH vs BLLN Comparison

CHH vs BLLN Comparison

Compare CHH & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Choice Hotels International Inc.

CHH

Choice Hotels International Inc.

N/A

Current Price

$116.69

Market Cap

4.7B

ML Signal

N/A

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$109.83

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHH
BLLN
Founded
1939
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.6B
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
CHH
BLLN
Price
$116.69
$109.83
Analyst Decision
Hold
Buy
Analyst Count
18
8
Target Price
$114.65
★ $129.00
AVG Volume (30 Days)
★ 502.5K
456.0K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 1.03%
N/A
EPS Growth
27.42
★ 103.40
EPS
★ 1.84
0.48
Revenue
★ $1,596,793,000.00
$305,112,000.00
Revenue This Year
$2.00
$49.33
Revenue Next Year
$3.49
$26.38
P/E Ratio
★ $60.38
$237.01
Revenue Growth
0.75
★ 99.97
52 Week Low
$84.04
$61.96
52 Week High
$123.82
$150.44

Technical Indicators

Market Signals
Indicator
CHH
BLLN
Relative Strength Index (RSI) 67.61 52.83
Support Level $103.66 $89.26
Resistance Level $123.82 $127.72
Average True Range (ATR) 3.56 5.53
MACD 0.48 1.15
Stochastic Oscillator 90.11 60.41

Price Performance

Historical Comparison
CHH
BLLN

About CHH Choice Hotels International Inc.

At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: